8/21/2014 | PP | Emisphere revises maturity dates of convertibles held by MHR lenders
|
5/9/2013 | PP | Emisphere amends terms of 13% convertibles held by MHR Fund Management
|
10/9/2012 | PP | Emisphere's convertibles will now accrue interest at 13% default rate
|
9/26/2012 | PP | Emisphere defaults on $31.1 million notes held by MHR Management
|
6/30/2011 | PP | Emisphere Technologies plans $7.5 million private placement of units
|
8/25/2010 | PP | Market Commentary: Biodel brings registered offering; Emisphere seeks $7.07 million; Darnley Bay closes unit sale
|
8/25/2010 | PP | New Issue: Emisphere to pocket $7.07 million through private placement of stock
|
5/27/2010 | PP | Emisphere extends maturity date of $10 million convertible to June 4
|
8/19/2009 | PP | New Issue: Emisphere Technologies plans to raise $8 million through selling stock
|
8/19/2009 | PP | Market Commentary: Empire Resorts to raise $65 million; Kirkland Lake upsizes units; Emisphere plans two deals
|
8/17/2007 | PP | New Issue: Emisphere Technologies sells $7.57 million units in registered direct offering
|
8/17/2007 | PP | Market Commentary: Emisphere issues $7.57 million; Valence sells $1 million in stock; Pegasus Oil negotiates C$12.01 million in shares
|
10/30/2006 | BT | Market Commentary: Sirna soars after hours on Merck $1.1 billion buyout; Emisphere plunges 24%; Point better by 19%
|
9/13/2006 | BT | Emisphere says next few months pivotal for eligen technology
|
9/5/2006 | BT | Emisphere's eligen aids in human growth hormone absorption, data shows
|
7/18/2006 | BT | Emisphere, Roche sign multi-product research agreement
|
6/21/2006 | BT | Emisphere granted waiver, extension from lender
|
5/25/2006 | BT | Novartis completes preclinical safety studies of oral calcitonin using Emisphere's technology
|
5/10/2006 | BT | Market Commentary: Alnylam gains as bird flu names slip; AVI pushes vaccine names lower; Novacea ends flat on debut
|
5/10/2006 | PP | Market Commentary: Emisphere gears up to wrap $33.04 million stock sale; Vivus to settle $12 million direct offering
|
5/10/2006 | BTPP | New Issue: Emisphere Technologies secures $33.04 million from direct placement of shares
|
5/5/2006 | BT | Emisphere reports 1Q net loss of $26.8 million, expects to run out of capital resources in mid-July
|
5/5/2006 | BT | Market Commentary: Northstar Neuroscience stock climbs on upsized IPO; Praecis stock jumps 22.3% on earnings
|
4/26/2006 | BT | Federal court orders Eli Lilly to assign intellectual property to Emisphere
|
4/12/2006 | BT | Emisphere gets new patent for eligen technology for pulmonary care
|
4/11/2006 | BT | Emisphere completes enrollment for phase 2 oral insulin clinical trial
|
4/7/2006 | BT | Emisphere Technologies files $48.3 million stock, warrant shelf
|
3/31/2006 | BT | Emisphere study shows eligen technology comparable to heparin by injection
|
3/23/2006 | BT | Genta, Emisphere sign license agreement for development of oral gallium compound
|
3/16/2006 | BT | Emisphere to run out of cash in May
|
3/8/2006 | BT | Emisphere announces oral PTH license agreement with Novartis
|
3/8/2006 | BT | Market Commentary: Alexza IPO gets off; Cepheid off; Dyax deal seen; Elan, Biogen up; Neurocrine shakes off trial miss
|
2/15/2006 | BT | Emisphere reaches second milestone in Roche collaboration, triggering payment
|
1/25/2006 | BT | White Mountain rates Emisphere at sell, drops coverage
|
12/12/2005 | BT | Emisphere announces positive results in trial of Oral CT with eligen for osteoarthritis
|
11/3/2005 | BT | Emisphere to begin phase-2 clinical trial for oral insulin
|
9/26/2005 | BTPP | Emisphere raises $15 million from term loan it may replace with convertible notes
|
4/1/2005 | PP | New Issue: Emisphere wraps direct placement of units for $15.74 million
|
4/1/2005 | PP | Market Commentary: Rentcash proposes C$24.65 million deal; oil reaches new highs, may spark new issuance
|
12/31/2004 | PP | New Issue: Emisphere gets $20 million equity line
|